Celldex Therapeutics, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Other eventsSep 22 →InsidersNo open-market buys. 2 insiders sold $1.3M, 0 of 2 sales on a 10b5-1 plan.→Financing →PeersClosest companies: EVMN, BHVN, ZBIO→
From the filings
Figures
- Revenue
- $865,000last 12 months
- Net income
- −$300.5Mlast 12 months
- Operating cash flow
- −$222.2Mlast 12 months
- Cash and equivalents
- $47.5Mat the last balance sheet
- Shares outstanding
- 78.5M shareson issue